NALP14 belongs to the NLR family, a crucial component in the innate immune system. This family has members involved in processes such as inflammation and apoptosis. Chemical activators for NALP14 are not extensively studied, but based on its classification, we can infer activators from those known to influence related proteins and pathways. Activation of NOD2 suggests that other family members, like NALP14, can also be influenced. Similarly, the role of TLR agonists like Pam3CSK4, Poly(I:C), and Imiquimod elucidates the intertwined nature of TLR and NLR signaling in immune responses. By modulating TLR pathways, there's a possibility to indirectly influence NALP14, given the common goal both families share in maintaining immune homeostasis.
It's probable that chemicals influencing one NLR protein can have indirect effects on others, including NALP14. Lastly, the impact of TLR agonists such as ODN 2006, CpG ODN, MALP-2, R837, and Gardiquimod showcases the broader immune signaling pathways. Activating these pathways can induce a cascade of responses, which can, in turn, modulate the activity or expression of proteins like NALP14. The interconnectedness of immune signaling makes it possible to indirectly influence specific proteins by targeting associated pathways or processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pam3Cys-Ser-(Lys)4, Hydrochloride | 112208-00-1 | sc-507471 | 2 mg | $550.00 | ||
TLR1/2 agonist. TLRs and NLRs share some immune responses. By activating TLR1/2, Pam3CSK4 can have indirect effects on NLR family members like NALP14. | ||||||
Aluminum hydroxide | 21645-51-2 | sc-214529 sc-214529A | 100 g 500 g | $39.00 $55.00 | 3 | |
Known to activate the NLRP3 inflammasome. If NALP14 has similar mechanisms to NLRP3, Alum can act as an indirect activator. | ||||||
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
TLR3 agonist. By stimulating TLR3, Poly(I:C) might influence NALP14 indirectly if there's an intersection in their immune pathways. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
TLR7 agonist. TLR7 activation can lead to indirect modulation of NALP14 given the intertwined nature of TLR and NLR signaling in immune responses. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $157.00 $282.00 $516.00 $1177.00 $20138.00 $32779.00 $70753.00 | 1 | |
TLR7 agonist. By targeting TLR7, Gardiquimod can modulate NALP14's function indirectly if they share common immune pathways or responses. | ||||||
Zymosan | 9010-72-4 | sc-296863 sc-296863A | 100 mg 1 g | $99.00 $599.00 | 1 | |
Recognized by TLR2/Dectin-1. Zymosan's influence on these receptors can lead to indirect effects on NALP14 due to shared immune system processes. | ||||||